共 50 条
- [1] Bone Mineral Content in Patients With Congenital Generalized Lipodystrophy Is Unaffected by Metreleptin Replacement Therapy JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08): : E1493 - E1500
- [2] METRELEPTIN THERAPY IN A PATIENT WITH CONGENITAL GENERALIZED LIPODYSTROPHY TYPE 4 HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 210 - 211
- [3] METRELEPTIN USE IN CHILDREN WITH CONGENITAL GENERALIZED LIPODYSTROPHY HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 577 - 577
- [5] Metreleptin Use in Children with Congenital Generalized Lipodystrophy HORMONE RESEARCH IN PAEDIATRICS, 2015, 84 : 30 - 30
- [7] Metreleptin Treatment in Three Patients with Generalized Lipodystrophy CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2016, 9 : 123 - 127
- [8] Effect of metreleptin on metabolic changes in patient with congenital generalized lipodystrophy HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 213 - 213
- [10] Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy NATIONAL MEDICAL JOURNAL OF INDIA, 2020, 33 (05): : 278 - 280